Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients (SWITCH)
This study has been completed.
Sponsor:
Genomic Health®, Inc.
Collaborator:
Registrat-Mapi
Information provided by (Responsible Party):
Genomic Health®, Inc.
ClinicalTrials.gov Identifier:
NCT01446185
First received: September 1, 2010
Last updated: April 17, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2012 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |